Testosterone replacement therapy in men on active surveillance for prostate cancer.
While the use of testosterone replacement therapy (TRT) in men undergoing active surveillance (AS) for prostate cancer (PCa) has been historically contraindicated, recent studies have contributed to a paradigm shift to this approach. To examine the impact …